| Chapter title |
Embelin and Its Role in Chronic Diseases
|
|---|---|
| Chapter number | 16 |
| Book title |
Anti-inflammatory Nutraceuticals and Chronic Diseases
|
| Published in |
Advances in experimental medicine and biology, January 2016
|
| DOI | 10.1007/978-3-319-41334-1_16 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-941332-7, 978-3-31-941334-1
|
| Authors |
Hong Lu, Jun Wang, Youxue Wang, Liang Qiao, Yongning Zhou |
| Abstract |
Embelia ribes Burm of Myrsinaceae family has been widely used as an herb in the traditional medicine of India. Embelin is an active component extracted from the fruits of Embelia ribes. It has a wide spectrum of biological activities and is not toxic at low dose. This review focuses on the physical-chemical properties and bioactivities of Embelin, as well as its effects on chronic diseases such as tumors, autoimmune inflammatory diseases, parasitic infections, microbial infections, diabetes, obesity, and cardio-cerebral vascular diseases. The underlying mechanisms of the effects are also discussed. As a multiple-targeted therapeutic agent, Embelin has the potential to be used widely for the treatment of a variety of chronic diseases, including malignant tumors. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 52 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 9 | 17% |
| Researcher | 7 | 13% |
| Student > Master | 6 | 12% |
| Professor > Associate Professor | 2 | 4% |
| Student > Bachelor | 2 | 4% |
| Other | 4 | 8% |
| Unknown | 22 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 13% |
| Biochemistry, Genetics and Molecular Biology | 6 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 10% |
| Agricultural and Biological Sciences | 5 | 10% |
| Engineering | 2 | 4% |
| Other | 6 | 12% |
| Unknown | 21 | 40% |